ArticleJournal of personalized medicine2021

Serum microRNAs as Tool to Predict Early Response to Benralizumab in Severe Eosinophilic Asthma.

José A Cañas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.